<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/529BA57C-BA0B-4947-A462-83A9DAED55B1"><gtr:id>529BA57C-BA0B-4947-A462-83A9DAED55B1</gtr:id><gtr:name>University of Toulouse</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3E18DACB-05AA-4C71-88FB-C909A8311BB5"><gtr:id>3E18DACB-05AA-4C71-88FB-C909A8311BB5</gtr:id><gtr:name>Birkbeck College</gtr:name><gtr:department>Biological Sciences</gtr:department><gtr:address><gtr:line1>Malet Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 7HX</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3E18DACB-05AA-4C71-88FB-C909A8311BB5"><gtr:id>3E18DACB-05AA-4C71-88FB-C909A8311BB5</gtr:id><gtr:name>Birkbeck College</gtr:name><gtr:address><gtr:line1>Malet Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 7HX</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/529BA57C-BA0B-4947-A462-83A9DAED55B1"><gtr:id>529BA57C-BA0B-4947-A462-83A9DAED55B1</gtr:id><gtr:name>University of Toulouse</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6F761512-C068-4DE5-B0A4-99E882912AB1"><gtr:id>6F761512-C068-4DE5-B0A4-99E882912AB1</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Kay</gtr:surname><gtr:orcidId>0000-0002-5200-6004</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0D242D83-8E74-4C64-A89E-E598DFD63B57"><gtr:id>0D242D83-8E74-4C64-A89E-E598DFD63B57</gtr:id><gtr:firstName>Tracey</gtr:firstName><gtr:surname>Barrett</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701236"><gtr:id>E2BB6B14-774D-4288-922E-758192145DBC</gtr:id><gtr:title>Investigating the molecular mechanisms underlying ks-vFLIP and endogenous activation of the NF-kB pathway.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701236</gtr:grantReference><gtr:abstractText>The main aim of our research is to understand at the atomic level how two essential cellular pathways (called the NF-?B canonical and non-canonical pathways) are activated by a viral protein linked to Kaposi Sarcoma, the main form of AIDS related cancer and a host protein of similar structure (implicated in immune cell development and non-viral cancer). For stimulation of the canonical pathway, both proteins have been found to interact with a component of an assembly of proteins known as the IKK complex that is thought to act as a molecular switch. Our studies will focus on how the host protein recognises this component (since this has already been done for the viral protein in a previous study) and how the molecular switch toggles between on and off states. To achieve this, we will use a technique known as protein crystallography that will enable us visualise the host protein bound to the IKK component in 3 dimensions and also the IKK component in isolation allowing comparison. This should ultimately aid in the design of novel anti-cancer drugs that specifically inhibit the transition. We aim to perform similar studies with our target proteins and components of the non-canonical pathway.</gtr:abstractText><gtr:technicalSummary>The canonical and non-canonical (or alternative) NF-kB pathways are key to cellular survival and are pivotal to the life cycle of several lymphoproliferative viruses. Following viral infection or the breakdown of the regulatory processes, both are rendered constitutively active culminating in the upregulated expression of anti-apoptotic and pro-survival genes. This has been associated with a number of malignancies that include cancer, lymphoproliferative disorders and auto-immune diseases. Understanding how these NF-kB pathways are activated by both endogenous and viral proteins at the molecular level is thus crucial for the development of novel therapeutics given that many of these disorders lack effective treatments. We therefore seek to establish the molecular basis underlying activation of the canonical and non-canonical NF-kB pathways by the Kaposi Sarcoma human herpes virus protein ks-vFLIP and to establish whether its cellular homologue p22-cFLIP utilises similar mechanisms. For stimulation of the canonical pathway, both ks-vFLIP and p22-cFLIP have been shown to interact with IKKgamma, an essential component of the IKK kinase. Having recently determined the crystal structure of ks-vFLIP bound to IKKgamma we wish to ascertain whether p22-cFLIP uses a similar mode of recognition through structural studies. It has been suggested that activation of the canonical pathway is dependent on a conformational transition within the IKKgamma molecule enabling it to act as a molecular switch. Using a biophysical approach, we aim to investigate the dynamics of this transition. By contrast to the canonical pathway, ks-vFLIP activation of the non-canonical pathway is achieved via a physical interaction with the transcriptional activator p100. We will analyse this interaction using a combination of structural biology and biochemical techniques and also establish whether p22-cFLIP can similarly contact p100 and thus activate the non-canonical NF-kB pathway that is so far unknown. We will also investigate downstream events to determine whether IKKgamma functions in the ks-vFLIP (and potentially p22-cFLIP) activation of the non-canonical pathway that is also unresolved.</gtr:technicalSummary><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>388686</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Integrative Biology</gtr:department><gtr:description>Understanding the molecular basis underlying viral egress and host shutoff in the KSHV virus</gtr:description><gtr:id>69EE6C1A-B1F2-48CF-BCA5-D7F5EB6B28F5</gtr:id><gtr:impact>An outcome of this collaboration has been a publications in Nucleic Acids research (July 2011 and January 2017). The collaboration is multidisciplinary involving structural biology, biochemistry/biophysics and cell/whole organism biology.</gtr:impact><gtr:outcomeId>gaXoYMhP5Lz-1</gtr:outcomeId><gtr:partnerContribution>Propriety access to cell biology and mutagenesis data that have informed biochemical and structural studies.</gtr:partnerContribution><gtr:piContribution>Expertise in structural biology and biochemical/biophysical assays</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Toulouse</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Department of Molecular Biology</gtr:department><gtr:description>Establishing the molecular basis underpinning the multiple functions of the essential pontin and reptin proteins</gtr:description><gtr:id>6B3F2BF0-8302-4872-B81B-FCCBC92D4379</gtr:id><gtr:impact>An outcome of this collaboration has been a publication in the journal Structure (2012). The collaboration is multi-disciplinary involving structural biology, molecular dynamics simulations, biochemistry and biophysics</gtr:impact><gtr:outcomeId>eQ7unnCsWG6-1</gtr:outcomeId><gtr:partnerContribution>Expertise in establishing the conformational dynamics of proteins involved in the formation of large macromolecular assemblies.</gtr:partnerContribution><gtr:piContribution>Expertise in Structural Biology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Publication in the journal Pharmacology matters</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4F53FB52-DA00-4110-8185-9E8BFB0F5E34</gtr:id><gtr:impact>Although currently difficult to establish, the publication will highlight our current research activities making this information available to health professionals in general.

Since the paper was only published in August 2013, it is difficult to comment on notable impacts at this stage.</gtr:impact><gtr:outcomeId>XuTGUWyBW2d</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.bps.ac.uk/SpringboardWebApp/userfiles/bps/file/Publications/Pharmacology_Matters/August2013%20FINALWEB.pdf</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A range of mutants have been produced for lentivirus transfection assays and also for the production of mutant proteins in E.coli expression systems.</gtr:description><gtr:id>61F791F1-FBCA-405D-BC54-09D83A959BDE</gtr:id><gtr:impact>These mutants contributed to a publication in The Journal of Virology (2011).</gtr:impact><gtr:outcomeId>mGfsxFT6gh8</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mutants</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>57A54DCF-4F77-4512-A776-E261009BDAFE</gtr:id><gtr:title>Crystal structure of a KSHV-SOX-DNA complex: insights into the molecular mechanisms underlying DNase activity and host shutoff.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10d863be397b7bd86429d0423349baf6"><gtr:id>10d863be397b7bd86429d0423349baf6</gtr:id><gtr:otherNames>Bagn?ris C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>qKtUewnmTNC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8F6F323-E322-446F-A95A-F99E29D16D5C</gtr:id><gtr:title>Kaposi's sarcoma-associated herpesvirus vFLIP and human T cell lymphotropic virus type 1 Tax oncogenic proteins activate IkappaB kinase subunit gamma by different mechanisms independent of the physiological cytokine-induced pathways.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b3036e18483c138459c64953c053bca"><gtr:id>0b3036e18483c138459c64953c053bca</gtr:id><gtr:otherNames>Shimizu A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>rKLZG6X1oQa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC806667-AAD9-462F-9D4E-24FBB6EFEA4F</gtr:id><gtr:title>IKK?-Mimetic Peptides Block the Resistance to Apoptosis Associated with Kaposi's Sarcoma-Associated Herpesvirus Infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/720fd71b1a034f89d224cdeaa6732206"><gtr:id>720fd71b1a034f89d224cdeaa6732206</gtr:id><gtr:otherNames>Briggs LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5aa1323dbbebc1.39344323</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94454C92-1FA2-450B-80F8-F7A4CE9F64C4</gtr:id><gtr:title>KSHV SOX mediated host shutoff: the molecular mechanism underlying mRNA transcript processing.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4835452f902a6cca2fd0be609e3178e"><gtr:id>c4835452f902a6cca2fd0be609e3178e</gtr:id><gtr:otherNames>Lee H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>58c131ec31ca19.41210827</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBE70B79-247E-41AE-9772-C20324CB2FE5</gtr:id><gtr:title>Probing the solution structure of I?B kinase (IKK) subunit ? and its interaction with Kaposi sarcoma-associated herpes virus Flice-interacting protein and IKK subunit ? by EPR spectroscopy.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10d863be397b7bd86429d0423349baf6"><gtr:id>10d863be397b7bd86429d0423349baf6</gtr:id><gtr:otherNames>Bagn?ris C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56d415711bb838.22024327</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CADE0E50-EB62-4638-9F65-C035DF896C24</gtr:id><gtr:title>Large-scale conformational flexibility determines the properties of AAA+ TIP49 ATPases.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8b15cf8a978e593f31e6330b999e5f0"><gtr:id>d8b15cf8a978e593f31e6330b999e5f0</gtr:id><gtr:otherNames>Petukhov M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_15599_29_22748767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>172952A3-B64C-4C37-914B-D6C71799A0E9</gtr:id><gtr:title>Distinct Activation Mechanisms of NF-?B Regulator Inhibitor of NF-?B Kinase (IKK) by Isoforms of the Cell Death Regulator Cellular FLICE-like Inhibitory Protein (cFLIP).</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/894aad60dedd49692f717b88f14b6c55"><gtr:id>894aad60dedd49692f717b88f14b6c55</gtr:id><gtr:otherNames>Baratchian M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56d416ecdf5e53.86921470</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A6CA83F-A8CB-4CDC-8780-728941EA0BCF</gtr:id><gtr:title>Crystal structure of the UvrB dimer: insights into the nature and functioning of the UvrAB damage engagement and UvrB-DNA complexes.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b58f8a6b208bc5fb17109d037d054878"><gtr:id>b58f8a6b208bc5fb17109d037d054878</gtr:id><gtr:otherNames>Webster MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_15599_29_22753105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EA5C313-D908-44E2-8BEF-D4AD432270E0</gtr:id><gtr:title>Therapeutic target-site variability in a1-antitrypsin characterized at high resolution.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91e8300a8f049deda4481c04366f44c3"><gtr:id>91e8300a8f049deda4481c04366f44c3</gtr:id><gtr:otherNames>Patschull AO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>pm_15599_29_22139150</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70BFFA29-76FF-4897-920D-927D34F547FF</gtr:id><gtr:title>Structural dynamics associated with intermediate formation in an archetypal conformational disease.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05ef27b40b42c70c0c49913ddaf4a28e"><gtr:id>05ef27b40b42c70c0c49913ddaf4a28e</gtr:id><gtr:otherNames>Nyon MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_15599_29_22405009</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701236</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>